Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) price closed lower on Monday, April 15, dropping -1.43% below its previous close.
A look at the daily price movement shows that the last close reads $2.10. The company’s 5Y monthly beta was ticking -0.93 while its P/E ratio in the trailing 12-month period read 2.94. Taking into account the 52-week price action we note that the stock hit a 52-week high of $31.77 and 52-week low of $2.07. The stock subtracted -34.70% on its value in the past month.
Amylyx Pharmaceuticals Inc, which has a market valuation of $140.30 million, is expected to release its quarterly earnings report May 10, 2024 – May 14, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give AMLX a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that AMLX’s price is at present -23.59% off the SMA20 and -79.09% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 19.47, with weekly volatility standing at 9.55%. The indicator jumps to 8.08% when calculated based on the past 30 days. Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s beta value is holding at -0.81, while the average true range (ATR) indicator is currently reading 0.52.
An analysis of the Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) stock in terms of its daily trading volume indicates that the 3-month average is 3.13 million.
Current records show that the company has 67.71M in outstanding shares. The insiders’ percentage holdings are 29.83% of outstanding shares while the percentage share held by institutions stands at 89.44%. But the -85.94% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
